Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00421 | 35091747 | J Nutr | Plasma Alkylresorcinol Metabolite, a Biomarker for Whole-Grain Intake, Is Inversely Associated with Risk of Nonalcoholic Fatty Liver Disease in a Case-Control Study of Chinese Adults. | 2022 | Details |
| A00422 | 35090960 | J Hepatol | Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD. | 2022 | Details |
| A00423 | 35089884 | Chin Med J (Engl) | Non-invasive tests of non-alcoholic fatty liver disease. | 2022 | Details |
| A00425 | 35089208 | Medicine (Baltimore) | Association between liver stiffness measurement by transient elastography and chronic kidney disease. | 2022 | Details |
| A00426 | 35089193 | Medicine (Baltimore) | Serum cadmium is associated with hepatic steatosis and fibrosis: Korean national health and nutrition examination survey data IV-VII. | 2022 | Details |
| A00428 | 35087774 | Front Pediatr | Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy. | 2022 | Details |
| A00429 | 35087411 | Front Pharmacol | Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways. | 2022 | Details |
| A00430 | 35087037 | Cell Death Dis | Long-term oral administration of an HNF4α agonist prevents weight gain and hepatic steatosis by promoting increased mitochondrial mass and function. | 2022 | Details |
| A00431 | 35086794 | Prim Care Diabetes | Metabolic dysfunction-associated fatty liver disease - How relevant is this to primary care physicians and diabetologists? | 2022 | Details |
| A00432 | 35086000 | Food Chem | Amelioration action of gastrodigenin rhamno-pyranoside from Moringa seeds on non-alcoholic fatty liver disease. | 2022 | Details |
| A00434 | 35085594 | J Hepatol | Associations of muscle mass and grip strength with severe NAFLD: A prospective study of 333,295 UK Biobank participants. | 2022 | Details |
| A00435 | 35085294 | PLoS One | Quantitative ultrasound, elastography, and machine learning for assessment of steatosis, inflammation, and fibrosis in chronic liver disease. | 2022 | Details |
| A00436 | 35085026 | Metab Syndr Relat Disord | Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00438 | 35084136 | Rev Med Suisse | [New approaches to risk and the use of electronic tools in primary care medicine in 2021]. | 2022 | Details |
| A00439 | 35083765 | Hepatology | Zac1 and the Imprinted Gene Network program juvenile NAFLD in response to maternal metabolic syndrome. | 2022 | Details |
| A00440 | 35083304 | Front Cardiovasc Med | Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis. | 2022 | Details |
| A00441 | 35083257 | Front Med (Lausanne) | Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease. | 2022 | Details |
| A00442 | 35082753 | Front Endocrinol (Lausanne) | Triglyceride-Rich Lipoproteins and Glycoprotein A and B Assessed by 1H-NMR in Metabolic-Associated Fatty Liver Disease. | 2022 | Details |
| A00443 | 35081304 | Diabetes Metab J | Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00444 | 35080508 | Clin Transl Gastroenterol | Metabolic Dysfunction-Associated Fatty Liver Disease Increases Colon Cancer Risk: A Nationwide Cohort Study. | 2022 | Details |
| A00445 | 35080136 | J Diabetes Investig | Non-alcoholic fatty liver disease and type 2 diabetes: An update. | 2022 | Details |
| A00446 | 35080048 | J Gastroenterol Hepatol | Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease. | 2022 | Details |
| A00447 | 35079935 | Mol Biol Rep | Physiological significance of bistable circuit design in metabolic homeostasis: role of integrated insulin-glucagon signalling network. | 2022 | Details |
| A00448 | 35079162 | Eur J Clin Nutr | Inflammatory potential of diet and risk of nonalcoholic fatty liver disease: a prospective cohort study. | 2022 | Details |
| A00449 | 35078487 | Chin Med | Red yeast rice ameliorates non-alcoholic fatty liver disease through inhibiting lipid synthesis and NF-κB/NLRP3 inflammasome-mediated hepatic inflammation in mice. | 2022 | Details |
| A00450 | 35077907 | Environ Toxicol Pharmacol | Enterobacter cloacae aggravates metabolic disease by inducing inflammation and lipid accumulation. | 2022 | Details |
| A00451 | 35077243 | J Cardiovasc Pharmacol Ther | The Association of Alanine Aminotransferase Levels With Myocardial Perfusion Imaging and Cardiovascular Morbidity. | 2022 | Details |
| A00452 | 35076304 | Radiology | US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative. | 2022 | Details |
| A00453 | 35076162 | Hepatol Commun | Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community-Based Sample of Mexican-Origin Adults. | 2022 | Details |
| A00455 | 35075592 | Hepatol Int | Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice. | 2022 | Details |
| A00456 | 35075477 | Lab Med | Serum Metabolomics in Patients with Coexisting NAFLD and T2DM Using Liquid Chromatography-Mass Spectrometry. | 2022 | Details |
| A00457 | 35075185 | Sci Rep | MAFLD progression contributes to altered thalamus metabolism and brain structure. | 2022 | Details |
| A00458 | 35074921 | Proc Natl Acad Sci U S A | Myeloid cell TBK1 restricts inflammatory responses. | 2022 | Details |
| A00459 | 35072848 | Inflammopharmacology | The effects of metformin, pioglitazone, exenatide and exercise on fatty liver in obese diabetic rats: the role of IRS-1 and SOCS-3 molecules. | 2022 | Details |
| A00460 | 35072542 | Antioxid Redox Signal | SPECIALIZED PRO-RESOLVING MEDIATORS DERIVED FROM N-3 POLYUNSATURATED FATTY ACIDS: ROLE IN METABOLIC SYNDROME AND RELATED COMPLICATIONS. | 2022 | Details |
| A00461 | 35072021 | JHEP Rep | Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance. | 2021 | Details |
| A00462 | 35071330 | Front Mol Biosci | HSD17B13: A Potential Therapeutic Target for NAFLD. | 2022 | Details |
| A00463 | 35071254 | Front Med (Lausanne) | Not Only High Number and Specific Comorbidities but Also Age Are Closely Related to Progression and Poor Prognosis in Patients With COVID-19. | 2022 | Details |
| A00464 | 35070304 | Mol Clin Oncol | Serine palmitoyltransferase long chain subunit 3 is associated with hepatocellular carcinoma in patients with NAFLD. | 2021 | Details |
| A00465 | 35070018 | World J Hepatol | Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study. | 2021 | Details |
| A00466 | 35070015 | World J Hepatol | Determination of "indeterminate score" measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia. | 2021 | Details |
| A00467 | 35070009 | World J Hepatol | Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis. | 2021 | Details |
| A00468 | 35070000 | World J Hepatol | Liver manifestations and complications in inflammatory bowel disease: A review. | 2021 | Details |
| A00469 | 35069993 | World J Hepatol | Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. | 2021 | Details |
| A00470 | 35069992 | World J Hepatol | Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence? | 2021 | Details |
| A00471 | 35069014 | Genet Res (Camb) | Inflammatory Cytokines, Adipocytokines, and Th17/Treg Balance in Patients with Nonalcoholic Fatty Liver Disease following Administration of Dahuang Zhechong Pills. | 2022 | Details |
| A00472 | 35068798 | J Clin Exp Hepatol | Diagnosis and Management of Cirrhotic Cardiomyopathy. | 2021 | Details |
| A00473 | 35068797 | J Clin Exp Hepatol | Magnetic Resonance Elastography for the Clinical Risk Assessment of Fibrosis, Cirrhosis, and Portal Hypertension in Patients With NAFLD. | 2021 | Details |
| A00474 | 35068796 | J Clin Exp Hepatol | A Current Understanding of Bile Acids in Chronic Liver Disease. | 2021 | Details |
| A00475 | 35068786 | J Clin Exp Hepatol | Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia-A Prospective, Interventional, Pilot Study. | 2021 | Details |
| A00476 | 35068681 | J Clin Biochem Nutr | A nutritional intervention that promotes increased vegetable intake in Japanese with non-alcoholic fatty liver disease: a six-month trial. | 2021 | Details |
| A00477 | 35068225 | Exp Biol Med (Maywood) | Impact of spexin on metabolic diseases and inflammation: An updated minireview. | 2022 | Details |
| A00478 | 35067753 | Eur J Nutr | The effects of fish oil plus vitamin D3 intervention on non-alcoholic fatty liver disease: a randomized controlled trial. | 2022 | Details |
| A00479 | 35067233 | Nutr Res Rev | MITOCHONDRIAL DYSFUNCTION AND EPIGENETICS UNDERLYING THE LINK BETWEEN EARLY-LIFE NUTRITION AND NON-ALCOHOLIC FATTY LIVER DISEASE. | 2022 | Details |
| A00480 | 35067116 | Ethn Health | Association of lifestyle behaviors with non-alcoholic fatty liver disease and advanced fibrosis detected by transient elastography among Hispanic/Latinos adults in the U.S. | 2022 | Details |
| A00481 | 35066992 | Liver Int | The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population-based follow-up study (NASHCO). | 2022 | Details |
| A00482 | 35066087 | J Hepatol | Is it time for chronopharmacology in NASH? | 2022 | Details |
| A00484 | 35065293 | Biochem Biophys Res Commun | Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine. | 2022 | Details |
| A00485 | 35065166 | Life Sci | Hepatocellular BChE as a therapeutic target to ameliorate hypercholesterolemia through PRMT5 selective degradation to restore LDL receptor transcription. | 2022 | Details |
| A00486 | 35064579 | J Pathol | Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis. | 2022 | Details |
| A00487 | 35064545 | Hepatol Int | The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study. | 2022 | Details |
| A00488 | 35064452 | Indian J Gastroenterol | Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors. | 2022 | Details |
| A00489 | 35064417 | Qual Life Res | The effect of polypharmacy on quality of life in adult patients with nonalcoholic fatty liver disease in the United States. | 2022 | Details |
| A00490 | 35063810 | Nutrition | Satellite cell content and muscle regeneration in a mouse model of NAFLD. | 2021 | Details |
| A00491 | 35063601 | J Hepatol | Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events. | 2022 | Details |
| A00492 | 35063496 | Diabetes Res Clin Pract | Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: A 15-year community-based prospective cohort study. | 2022 | Details |
| A00493 | 35063242 | Clin Nutr ESPEN | Effect of Cornus mas L. fruit extract on lipid accumulation product and cardiovascular indices in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled trial. | 2021 | Details |
| A00494 | 35062050 | Biomed Pharmacother | CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver. | 2022 | Details |
| A00495 | 35061826 | PLoS One | A nationwide survey of the association between nonalcoholic fatty liver disease and the incidence of asthma in Korean adults. | 2022 | Details |
| A00496 | 35061665 | PLoS Biol | Rab2A regulates the progression of nonalcoholic fatty liver disease downstream of AMPK-TBC1D1 axis by stabilizing PPARγ. | 2022 | Details |
| A00497 | 35061559 | Arch Physiol Biochem | Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats. | 2022 | Details |
| A00498 | 35061189 | Curr Oncol Rep | Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications. | 2022 | Details |
| A00499 | 35060922 | Endocr Connect | Association between thyroid function and assessment of hepatic fat and iron contents by magnetic resonance imaging. | 2022 | Details |
| A00500 | 35060815 | Expert Opin Investig Drugs | Nonalcoholic steatohepatitis (NASH) cirrhosis: a snapshot of therapeutic agents in clinical development and the optimal design for clinical trials. | 2022 | Details |
| A00501 | 35060744 | J Med Chem | Design, Synthesis, and Biological Evaluation of Triazolone Derivatives as Potent PPARα/δ Dual Agonists for the Treatment of Nonalcoholic Steatohepatitis. | 2022 | Details |
| A00502 | 35060066 | Hepatol Int | Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease. | 2022 | Details |
| A00503 | 35059041 | Dis Markers | Pentraxin 3 and the TyG Index as Two Novel Markers to Diagnose NAFLD in Children. | 2021 | Details |
| A00504 | 35058782 | Front Pharmacol | TMEM88 Modulates Lipid Synthesis and Metabolism Cytokine by Regulating Wnt/β-Catenin Signaling Pathway in Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A00505 | 35058605 | Eur J Clin Nutr | Effects of a low free sugar diet on the management of nonalcoholic fatty liver disease: a randomized clinical trial. | 2022 | Details |
| A00506 | 35058529 | Sci Rep | Pcyt2 deficiency causes age-dependant development of nonalcoholic steatohepatitis and insulin resistance that could be attenuated with phosphoethanolamine. | 2022 | Details |
| A00507 | 35058515 | Sci Rep | Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease. | 2022 | Details |
| A00508 | 35058147 | Eur J Intern Med | Derivation and validation of the NAFLD Cirrhosis Score (NCS) to distinguish bridging fibrosis from cirrhosis. | 2022 | Details |
| A00509 | 35057689 | Expert Rev Gastroenterol Hepatol | Research progress on the relationship between TM6SF2 rs58542926 polymorphism and non-alcoholic fatty liver disease. | 2022 | Details |
| A00510 | 35057565 | Nutrients | Switching to Regular Diet Partially Resolves Liver Fibrosis Induced by High-Fat, High-Cholesterol Diet in Mice. | 2022 | Details |
| A00511 | 35057439 | Nutrients | Mediterranean Diet and Fatty Liver Risk in a Population of Overweight Older Italians: A Propensity Score-Matched Case-Cohort Study. | 2022 | Details |
| A00512 | 35056346 | Medicina (Kaunas) | Colonic Diverticulosis and Non-Alcoholic Fatty Liver Disease: Is There a Connection? | 2021 | Details |
| A00513 | 35055797 | Int J Environ Res Public Health | Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study. | 2022 | Details |
| A00514 | 35055407 | J Pers Med | Decrease in Sleep Duration and Poor Sleep Quality over Time Is Associated with an Increased Risk of Incident Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A00515 | 35055177 | Int J Mol Sci | Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal Akkermansia Genus Level. | 2022 | Details |
| A00516 | 35054924 | Int J Mol Sci | GLP-1a: Going beyond Traditional Use. | 2022 | Details |
| A00517 | 35054847 | Int J Mol Sci | The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A00518 | 35054837 | Int J Mol Sci | The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A00519 | 35054478 | Life (Basel) | Deep Sea Water-Dissolved Organic Matter Intake Improves Hyperlipidemia and Inhibits Thrombus Formation and Vascular Inflammation in High-Fat Diet Hamsters. | 2022 | Details |
| A00520 | 35054428 | Life (Basel) | The Possible Association of Non-Alcoholic Fatty Liver Disease with Acute Cholangitis: A Retrospective Multicenter Cohort Study. | 2021 | Details |
| A00521 | 35053962 | Foods | Limosilactobacillus fermentum MG4295 Improves Hyperglycemia in High-Fat Diet-Induced Mice. | 2022 | Details |
| A00522 | 35053629 | Children (Basel) | Cardiovascular Risk Factors and Subclinical Atherosclerosis in Greek Adolescents with Polycystic Ovary Syndrome: Its Relationship with Body Mass Index. | 2021 | Details |
| A00523 | 35053625 | Cancers (Basel) | Correction: Lai et al. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling. Cancers 2021, 13, 940. | 2022 | Details |
| A00524 | 35053404 | Cells | Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver. | 2022 | Details |
| A00525 | 35053253 | Biomolecules | Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis. | 2022 | Details |
| A00526 | 35053205 | Biomolecules | Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. | 2021 | Details |